TIMP1 and heart failure: Meanwhile, in a study by Chen et al. (2022), inhibition of this pathway by dapagliflozin reduced the expression of MMP-2, MMP-9 and TIMP-1 (p < 0.05), thereby improving fibrosis in normoglycemic heart failure rabbit models [36].